European Journal of Surgical Oncology
Volume 33, Issue 1 , Pages 28-32, February 2007

Local recurrence in breast carcinoma patients with T1–2 and 1–3 positive nodes: Indications for radiotherapy

Ankara Oncology Training and Research Hospital, Department of Surgery, Konutkent-2, A-4 Blok 44, Cayyolu, 06530, Ankara, Turkey

Accepted 11 October 2006.

Abstract 

Aims

To investigate the relationship between local recurrence (LR) and distant recurrence (DR) and to determine a subgroup of patients who could benefit from radiotherapy among breast carcinoma patients with T1–2 and N1a.

Methods

Univariate and multivariate Cox regression analyses were carried out in the retrospective data of 326 eligible patients.

Results

Fourteen (4.3%) patients had LR and 46 (14.1%) patients suffered DR, in their follow-up periods. The multivariate time-dependent Cox model for DR showed that ratio of positive nodes (PN) (p=0.004; hazard ratio (HR), 1.05; 95% confidence interval (CI), 1.02–1.09) and LR (p=0.05; HR, dependent on time) were strongly associated with DR. In the multivariate Cox analysis for LR, age (≤35 years vs >35 years; p<0.0001; HR, 6.8; CI, 2.3–19.9), lymphatic vascular invasion (LVI) (yes vs no; p=0.03; HR, 3.3; CI, 1.2–9.8), and a ratio of PN (>15% vs ≤15%; p<0.0001; HR, 13.0; CI, 3.9–42.0) were the most important prognostic factors. Whereas patients with 2 or 3 risk factors were accepted as the high risk group for LR, those with no or 1 risk factor were considered as the low risk group. These groups had a 23% LR rate and a 2.7% LR rate, respectively (p<0.0001).

Conclusions

This report confirmed the importance of local recurrence for distant recurrence. Age, ratio of PN and LVI were the most important prognostic factors for LR. The T1–2 and N1a patients who had 2 or 3 risk factors might benefit from radiotherapy.

Keywords: Breast carcinoma, 1–3 positive nodes, Prognosis, Ratio, Radiotherapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0748-7983(06)00408-2

doi:10.1016/j.ejso.2006.10.022

European Journal of Surgical Oncology
Volume 33, Issue 1 , Pages 28-32, February 2007